Skip to main content

View full-text article in PMC

. 2021 Feb 13;7(2):e06256. doi: 10.1016/j.heliyon.2021.e06256

Table 5.

Comparison of mean scores of the domains of IOFS by treatment cost, type, and duration of cancer.

Attributes		Financial burden		Social impact		Personal strain		Mastery		Total IOFS score
Attributes		Mean	p-value	Mean	p-value	Mean	p-value	Mean	p-value	Mean	p-value
Type of cancer	Leukemia	13.15	0.370^b	27.71	0.000^b∗	19.10	0.055^b∗	17.75	0.001^b∗	77.71	0.000^b∗
	Lymphoma	13.70		29.20		19.77		17.53		80.20
	Blastoma	13.32		29.81		20.05		18.87		82.05
	Sarcoma	13.17		29.00		19.83		18.44		80.44
	Others	13.56		29.96		20.00		18.42		80.00
Duration of cancer (Months)	1–6	12.89	0.000^b∗	27.86	0.000^b∗	19.19	0.000^b∗	17.86	0.002^b∗	77.80	0.000^b∗
	7–12	14.0		30.67		20.44		18.73		83.84
	13–18	14.24		30.12		19.94		18.18		82.47
Direct cost	1500–50000	13.14	0.408^b	27.76	0.000^b∗	19.18	0.002^b∗	18.35	0.178^b	78.43	0.001^b∗
	50001–100000	13.42		29.56		19.66		17.96		80.61
	100001–200000	13.40		28.93		20.73		18.47		81.53
Indirect cost	1000–10000	13.30	0.699^a	28.37	0.000^a∗	19.60	0.699^a	18.38	0.001^a∗	79.65	0.052^a
Indirect cost	10001–20000	13.39	0.699^a	30.34	0.000^a∗	19.72	0.699^a	17.53	0.001^a∗	80.98	0.052^a
Total cost	20000–50000	13.12	0.397^b	27.74	0.000^b∗	19.38	0.084^b	18.61	0.033^b	78.84	0.054^b
	50001–100000	13.43		29.54		19.57		17.93		80.47
	100001–200000	13.36		28.67		20.28		18.13		80.44

∗Significant at corrected p < 0.01.

^a

Independent sample t-test.

^b

One-way ANOVA (F-test).